المؤلفون: Santa-Maria CA, Nanda R

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2018 Oct; Vol. 16 (10), pp. 1259-1268.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biomarkers, Tumor/*antagonists & inhibitors , Breast Neoplasms/*drug therapy, Antineoplastic Agents, Immunological/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/genetics ; B7-H1 Antigen/immunology ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/immunology ; Breast/pathology ; Breast/surgery ; Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/genetics ; CTLA-4 Antigen/immunology ; Chemoradiotherapy, Adjuvant/methods ; Clinical Trials as Topic ; Female ; Humans ; Mastectomy ; Molecular Targeted Therapy ; Neoadjuvant Therapy/methods ; Precision Medicine/methods ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/genetics ; Programmed Cell Death 1 Receptor/immunology ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Treatment Outcome